Your browser is no longer supported. Please, upgrade your browser.
Settings
CORT Corcept Therapeutics Incorporated daily Stock Chart
CORT [NASD]
Corcept Therapeutics Incorporated
Index- P/E11.12 EPS (ttm)1.45 Insider Own0.90% Shs Outstand123.22M Perf Week23.54%
Market Cap1.99B Forward P/E16.41 EPS next Y0.98 Insider Trans36.70% Shs Float104.41M Perf Month28.67%
Income185.00M PEG- EPS next Q0.17 Inst Own79.40% Short Float23.17% Perf Quarter11.95%
Sales237.70M P/S8.35 EPS this Y- Inst Trans2.51% Short Ratio17.83 Perf Half Y-16.87%
Book/sh2.24 P/B7.19 EPS next Y65.88% ROA58.50% Target Price19.20 Perf Year-6.77%
Cash/sh1.58 P/C10.17 EPS next 5Y-11.90% ROE66.80% 52W Range11.21 - 25.96 Perf YTD-10.80%
Dividend- P/FCF16.71 EPS past 5Y39.00% ROI85.00% 52W High-37.94% Beta1.35
Dividend %- Quick Ratio5.40 Sales past 5Y117.00% Gross Margin98.00% 52W Low43.71% ATR1.07
Employees136 Current Ratio5.60 Sales Q/Q50.50% Oper. Margin36.30% RSI (14)63.90 Volatility14.52% 7.26%
OptionableYes Debt/Eq0.00 EPS Q/Q28.50% Profit Margin63.80% Rel Volume2.09 Prev Close17.19
ShortableYes LT Debt/Eq0.00 EarningsNov 01 AMC Payout0.00% Avg Volume1.36M Price16.11
Recom2.40 SMA2017.14% SMA5022.80% SMA2006.41% Volume2,840,580 Change-6.28%
Aug-10-18Reiterated Stifel Hold $20 → $11
May-31-18Downgrade Stifel Buy → Hold $20
Mar-09-18Initiated B. Riley FBR, Inc. Buy $30
Aug-31-17Initiated Stifel Buy $20
Feb-02-17Initiated Ladenburg Thalmann Buy $14
Apr-21-15Initiated FBR Capital Outperform $12
Jan-13-14Downgrade Stifel Buy → Hold
Aug-09-13Downgrade Ladenburg Thalmann Buy → Neutral $3.30
Aug-09-13Downgrade Janney Buy → Neutral
Feb-21-12Reiterated JMP Securities Mkt Outperform $9 → $11
Jan-06-10Upgrade Ladenburg Thalmann Neutral → Buy $4
Jul-17-08Initiated Rodman & Renshaw Mkt Outperform $8
Jun-21-07Upgrade Punk, Ziegel & Co Mkt Perform → Accumulate
Dec-13-18 09:30AM  Biotech Companies in the News ACCESSWIRE
08:35AM  Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushings Syndrome GlobeNewswire
Dec-12-18 04:43PM  IBD 50 Stocks To Watch: Corcept Expected To Pick Up Growth In 2019 Investor's Business Daily
06:50AM  Today's Research Reports on Trending Tickers: MYOS RENS Technology and Corcept Therapeutics ACCESSWIRE
Dec-11-18 04:58PM  Here's Why Corcept Therapeutics Surged Today Motley Fool +32.28%
04:26PM  Here's Why Corcept Therapeutics Rose 18.6% in November Motley Fool
Nov-30-18 08:15AM  Report: Exploring Fundamental Drivers Behind Tesla, Nordson, Paycom Software, PDL BioPharma, Corcept Therapeutics, and Willis Towers Watson Public New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-26-18 08:35AM  What You Must Know About Corcept Therapeutics Incorporateds (NASDAQ:CORT) Financial Strength Simply Wall St. +5.11%
Nov-20-18 04:24PM  Corcept Initiates Phase III Study for Cushing's Syndrome Zacks
Nov-19-18 09:05AM  Corcept Therapeutics Announces First Patient Dosed in Phase 3 Trial of Relacorilant to Treat Patients with Cushings Syndrome GlobeNewswire -7.14%
Nov-14-18 09:46PM  Edited Transcript of CORT earnings conference call or presentation 1-Nov-18 9:00pm GMT Thomson Reuters StreetEvents
Nov-05-18 02:25PM  Corcept (CORT) Q3 Earnings In Line, Revenues Miss Estimates Zacks
Nov-01-18 08:15PM  Corcept Therapeutics (CORT) Meets Q3 Earnings Estimates Zacks
07:09PM  Corcept: 3Q Earnings Snapshot Associated Press
04:05PM  Corcept Therapeutics Announces Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Oct-31-18 02:52PM  Is Corcept Therapeutics Incorporateds (NASDAQ:CORT) CEO Incentives Align With Yours? Simply Wall St.
Oct-25-18 04:05PM  Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Oct-24-18 08:05AM  Judge Denies Teva Pharmaceuticals Motion to Dismiss Corcept Therapeutics Allegations of Patent Infringement GlobeNewswire -7.99%
Oct-23-18 09:00AM  Report: Exploring Fundamental Drivers Behind Corcept Therapeutics, News Corporation, Nightstar Therapeutics PLC Sponsored ADR, Rudolph Technologies, Applied Optoelectronics, and United Rentals New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-04-18 10:08AM  Should You Be Holding Corcept Therapeutics Incorporated (NASDAQ:CORT) Right Now? Simply Wall St. -5.93%
Oct-01-18 07:15AM  Corcept Therapeutics Receives Orphan Designation for Relacorilant as Treatment for Pancreatic Cancer GlobeNewswire
Sep-12-18 08:52AM  Do Options Traders Know Something About Corcept (CORT) Stock We Don't? Zacks
Sep-04-18 08:03AM  Why These Fundamentals Make Corcept Therapeutics Incorporated (NASDAQ:CORT) Truly A Standout Investment Simply Wall St.
Aug-30-18 06:04PM  8 Stocks Joel Greenblatt Continues to Buy GuruFocus.com
Aug-29-18 07:35AM  Analysis: Positioning to Benefit within ShotSpotter, Frank's International N.V., Taseko Mines, Office Depot, Rudolph Technologies, and Corcept Therapeutics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +7.40%
Aug-26-18 11:55PM  Edited Transcript of CORT earnings conference call or presentation 9-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-25-18 06:01PM  Insider Buys Of The Week: Andeavor, Corcept, Portola Benzinga
Aug-24-18 07:30AM  [$$] Corcept Director Abruptly Switches to Buying Stock From Selling Barrons.com
Aug-20-18 04:57PM  3 High-Growth Stocks That Could Soar Motley Fool
Aug-10-18 12:38PM  Here's Why Corcept Therapeutics Inc. Fell as Much as 17.4% Today Motley Fool -5.15%
10:59AM  Corcept (CORT) Earnings and Revenues Miss Estimates in Q2 Zacks
08:00AM  Today's Research Reports on Trending Tickers: Puma Biotechnology and Corcept Therapeutics ACCESSWIRE
07:38AM  The Daily Biotech Pulse: Puma, CareDx Soar On Earnings, Corcept Plunges On Bottom-Line Miss Benzinga
Aug-09-18 06:30PM  Corcept Therapeutics (CORT) Misses Q2 Earnings and Revenue Estimates Zacks
05:26PM  Corcept: 2Q Earnings Snapshot Associated Press
04:05PM  Corcept Therapeutics Announces Second Quarter 2018 Financial Results and Stock Repurchase Program; Provides Clinical Update GlobeNewswire
03:00PM  Corcept Therapeutics Incorporated. to Host Earnings Call ACCESSWIRE
Aug-02-18 04:05PM  Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Jul-27-18 07:35AM  Initiating Free Research Reports on Celgene and Three Other Biotech Equities ACCESSWIRE
Jun-29-18 09:23AM  Options Traders Expect Huge Moves in Corcept Therapeutics (CORT) Stock Zacks
08:15AM  Analysis: Positioning to Benefit within QEP Resources, Corcept Therapeutics, Buckle, Noble Energy, Windstream, and Camden Property Trust Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jun-27-18 10:04AM  How Corcept Therapeutics Incorporated (NASDAQ:CORT) Delivered A Better ROE Than Its Industry Simply Wall St.
Jun-25-18 07:05AM  Today's Free Research Reports Coverage on CorMedix and Three More Biotech Stocks ACCESSWIRE
Jun-19-18 02:05PM  Corcept Therapeutics Incorporated (NASDAQ:CORT) Has Attractive Fundamentals, Heres Why Simply Wall St.
08:20AM  Today's Research Reports on Trending Tickers: Corcept Therapeutics and CRISPR Therapeutics ACCESSWIRE
Jun-07-18 09:42AM  Corcept Therapeutics (CORT) Up 6.6% Since Earnings Report: Can It Continue? Zacks
Jun-04-18 05:30AM  Corcept Therapeutics Announces Positive Relacorilant Data at the 2018 American Society of Clinical Oncology Meeting GlobeNewswire
May-31-18 12:52PM  Corcept Therapeutics Is 'Fairly Valued,' Stifel Says In Downgrade Benzinga -6.04%
May-25-18 08:30AM  Today's Research Reports on Trending Tickers: Corcept Therapeutics and Verastem ACCESSWIRE
May-21-18 08:00AM  Today's Research Reports on Trending Tickers: Nektar Therapeutics and Corcept Therapeutics ACCESSWIRE
May-17-18 04:13PM  Gilead, BioMarin among Bay Area drug makers shamed by FDA in generics 'gaming' list American City Business Journals
07:50AM  Market Trends Toward New Normal in Agios Pharmaceuticals, Corcept Therapeutics, Prestige Brand, Virtu Financial, Eagle Pharmaceuticals, and Century Aluminum Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
May-16-18 08:30AM  Corcept Therapeutics Announces Presentations at the American Association of Clinical Endocrinologists 27th Annual Congress GlobeNewswire
May-14-18 08:40AM  Is the Options Market Predicting a Spike in Corcept Therapeutics (CORT) Stock? Zacks +5.93%
May-12-18 10:02AM  May Undervalued Stock Opportunities Simply Wall St.
May-11-18 07:46PM  Edited Transcript of CORT earnings conference call or presentation 8-May-18 9:00pm GMT Thomson Reuters StreetEvents
May-08-18 06:55PM  Corcept: 1Q Earnings Snapshot Associated Press
04:05PM  Corcept Therapeutics Announces First Quarter 2018 Financial results and Provides Corporate Update GlobeNewswire
May-01-18 04:05PM  Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Apr-30-18 10:42AM  Corcept Therapeutics Incorporated (NASDAQ:CORT): Is It A Good Long Term Opportunity? Simply Wall St.
Apr-17-18 07:09PM  Should You Be Tempted To Buy Corcept Therapeutics Incorporated (NASDAQ:CORT) At Its Current PE Ratio? Simply Wall St.
Apr-06-18 02:23PM  10 Healthcare Stocks to Stave Off the Market Flu InvestorPlace
Mar-26-18 04:36AM  Why Is Corcept Therapeutics (CORT) Up 5.3% Since Its Last Earnings Report? Zacks
Mar-23-18 01:20PM  Edited Transcript of CORT earnings conference call or presentation 22-Feb-18 10:00pm GMT Thomson Reuters StreetEvents
Mar-15-18 05:00PM  Corcept Therapeutics Files Lawsuit Against Teva Pharmaceuticals for Infringement of Korlym Patents GlobeNewswire
Mar-12-18 12:45PM  Why Corcept Therapeutics Incorporated Lost 34% in February Motley Fool +5.20%
Mar-09-18 06:18PM  How Did Corcept Therapeutics Incorporateds (NASDAQ:CORT) 67.61% ROE Fare Against The Industry? Simply Wall St.
Mar-08-18 07:24PM  Corcept Plans Korlym Label Expansion, Pipeline in Progress Zacks
Mar-02-18 07:40AM  Wired News Sangamo Gets CTA from UK Agency for Evaluating SB-FIX for Treatment of Hemophilia B ACCESSWIRE
07:35AM  New Research: Key Drivers of Growth for Corcept Therapeutics, HubSpot, Tableau Software, Balchem, Steelcase, and Chimerix Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-23-18 08:55AM  Corcept's (CORT) Earnings and Sales Meet Estimates in Q4 Zacks
Feb-22-18 06:31PM  Corcept misses 4Q profit forecasts Associated Press
04:05PM  Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial GlobeNewswire
01:00PM  Corcept Therapeutics Incorporated. to Host Earnings Call ACCESSWIRE
Feb-15-18 04:05PM  Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2017 Financial Results, Provide Corporate Update, Host Conference Call GlobeNewswire
Feb-13-18 05:12PM  Why Corcept Therapeutics Stock Gained 27.4% in January Motley Fool
Feb-07-18 07:16PM  Cramer's lightning round: Buy Target on its revamped stra... CNBC Videos
06:48PM  Cramer's lightning round: Buy Target on its revamped strategy CNBC
Feb-05-18 04:30PM  These Biotech Stocks Each Dived More Than 20% Is The Sell-Off Overdone? Investor's Business Daily -26.43%
03:40PM  Why Corcept Therapeutics Incorporated Stock Is Getting Clobbered Today Motley Fool
08:49AM  Corcept's stock tumbles after Teva submits NDA for generic Korlym MarketWatch
Feb-01-18 04:02PM  Biotech Roundup: Who's Popping On Drug, Merger, Earnings News? Investor's Business Daily +5.54%
08:30AM  Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance GlobeNewswire
Jan-31-18 08:20AM  Todays Research Reports on Trending Tickers: Bellicum Pharmaceuticals and Corcept Therapeutics ACCESSWIRE
Jan-18-18 12:24PM  Harry Boxers four breakout stocks to watch include Universal Display MarketWatch +6.26%
Jan-10-18 05:59PM  Corcept Therapeutics Stock Has Healthy Institutional Support Investopedia
Jan-05-18 08:10AM  Analysis: Positioning to Benefit within Perry Ellis International, AutoZone, Corcept Therapeutics, LCI Industries, LegacyTexas Financial Group, and Micronet Enertec Technologies Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jan-03-18 10:03AM  Trevena Announces FDA Acceptance of Olinvo NDA, Shares Up Zacks
09:55AM  Achaogen's NDA for Plazomicin Gets Priority Review From FDA Zacks
Dec-29-17 11:45AM  ETFs with exposure to Corcept Therapeutics, Inc. : December 29, 2017 Capital Cube
09:55AM  TherapeuticsMD Submits NDA for VMS Candidate, Shares Rise Zacks
Dec-28-17 07:05PM  What Should We Expect From Corcept Therapeutics Incorporateds (NASDAQ:CORT) Earnings Over The Next Few Years? Simply Wall St.
09:45AM  Actinium Posts Positive DMC View on Lomab-B Phase III Trial Zacks
09:21AM  Horizon Pharma Gets FDA Nod for Procysbi Label Expansion Zacks
Dec-27-17 11:29AM  Insys' Cannabidiol Gets Fast Track Designation in the U.S. Zacks -6.23%
08:14AM  Why is Corcept's Stock Up More Than 150% So Far This Year? Zacks
08:11AM  Alexion's (ALXN) Soliris Label Expansion Approved in Japan Zacks
Dec-26-17 09:45AM  Merck's Diabetes Drugs Get FDA Nod as Adjunct Therapies Zacks +5.03%
09:17AM  BioMarin's (BMRN) Pegvaliase Review Period Extended by FDA Zacks
Dec-25-17 07:17AM  Corcept Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CORT-US : December 25, 2017 Capital Cube
Corcept Therapeutics Incorporated, a pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery, as well as develops CLIA-validated assay to measure FKBP5 gene expression. It is developing relacorilant that is in a Phase II trial to treat patients with Cushing's syndrome; abraxane in combination with relacorilant, which is in Phase I/II open label trial to treat solid tumors; and selective cortisol modulator CORT125281 combined with Xtandi that is in open label Phase I/II trial to treat patients with metastatic castration-resistant prostate cancer. The company is also developing CORT118335 selective cortisol modulator, which is in Phase I/II open label trial for the treatment of antipsychotic-induced weight gain and non-alcoholic steatotic hepatitis. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maduck SeanSee RemarksDec 13Option Exercise2.2410,00022,40030,024Dec 14 08:12 PM
Maduck SeanSee RemarksDec 12Option Exercise2.7860,000166,80680,024Dec 14 08:12 PM
BELANOFF JOSEPH KChief Executive OfficerDec 12Option Exercise1.19217,115258,3672,381,310Dec 14 07:50 PM
Robb Gary CharlesChief Financial OfficerDec 12Option Exercise1.9225,00048,00021,858Dec 14 07:51 PM
Robb Gary CharlesChief Financial OfficerDec 12Sale19.0125,000475,1536,858Dec 14 07:51 PM
BELANOFF JOSEPH KChief Executive OfficerDec 12Sale19.01217,1154,126,5092,164,195Dec 14 07:50 PM
Maduck SeanSee RemarksDec 12Sale19.0160,0001,140,36620,024Dec 14 08:12 PM
BAKER G LEONARD JRDirectorNov 21Buy12.7370,000890,7853,044,793Nov 26 05:13 PM
BAKER G LEONARD JRDirectorNov 21Buy12.7330,000381,765966,838Nov 26 05:13 PM
BAKER G LEONARD JRDirectorNov 13Buy12.8725,420327,1052,974,793Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 13Buy12.8710,895140,197936,838Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 12Buy12.9473,914956,6982,949,373Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 12Buy12.9431,677410,008925,943Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 09Buy13.0040,666528,6582,875,459Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 09Buy13.0017,428226,564894,266Nov 14 05:26 PM
FISHMAN ROBERT SChief Medical OfficerNov 07Option Exercise3.518,00028,0808,000Nov 09 05:06 PM
FISHMAN ROBERT SChief Medical OfficerNov 07Sale13.748,000109,8870Nov 09 05:06 PM
FISHMAN ROBERT SChief Medical OfficerOct 08Option Exercise3.518,00028,0808,000Oct 09 05:11 PM
FISHMAN ROBERT SChief Medical OfficerOct 08Sale13.198,000105,5380Oct 09 05:11 PM
FISHMAN ROBERT SChief Medical OfficerSep 07Option Exercise3.518,00028,0808,000Sep 11 04:36 PM
FISHMAN ROBERT SChief Medical OfficerSep 07Sale14.578,000116,5330Sep 11 04:36 PM
BAKER G LEONARD JRDirectorAug 20Buy12.9235,681461,0952,834,793Aug 22 05:54 PM
BAKER G LEONARD JRDirectorAug 17Buy12.805,79274,1172,799,112Aug 20 06:19 PM
BAKER G LEONARD JRDirectorAug 16Buy12.49100,0001,248,7602,793,320Aug 20 06:19 PM
BAKER G LEONARD JRDirectorAug 15Buy12.4979,686994,9672,693,320Aug 16 05:51 PM
BAKER G LEONARD JRDirectorAug 14Buy12.47100,0001,247,000876,838Aug 16 05:51 PM
FISHMAN ROBERT SChief Medical OfficerAug 07Option Exercise3.518,00028,0808,000Aug 08 05:20 PM
FISHMAN ROBERT SChief Medical OfficerAug 07Sale14.158,000113,1850Aug 08 05:20 PM
FISHMAN ROBERT SChief Medical OfficerJul 06Option Exercise3.518,00028,0808,000Jul 09 07:50 PM
FISHMAN ROBERT SChief Medical OfficerJul 06Sale15.098,000120,6860Jul 09 07:50 PM
WILSON JAMES NDirectorJun 29Option Exercise2.3010,00023,00010,000Jul 02 06:44 PM
FISHMAN ROBERT SChief Medical OfficerJun 07Option Exercise3.518,00028,0808,000Jun 11 05:07 PM
FISHMAN ROBERT SChief Medical OfficerJun 07Sale18.238,000145,8260Jun 11 05:07 PM
Maduck SeanSee RemarksMay 15Option Exercise2.2410,00022,40020,024May 17 05:27 PM
BAKER G LEONARD JRDirectorMay 11Option Exercise2.2330,00066,900806,838May 15 05:30 PM
BAKER G LEONARD JRDirectorMay 11Sale16.0130,000480,312776,838May 15 05:30 PM
FISHMAN ROBERT SChief Medical OfficerMay 07Option Exercise3.518,00028,0808,000May 08 06:54 PM
FISHMAN ROBERT SChief Medical OfficerMay 07Sale17.688,000141,4280May 08 06:54 PM
FISHMAN ROBERT SChief Medical OfficerApr 06Option Exercise3.518,00028,0808,000Apr 09 05:57 PM
FISHMAN ROBERT SChief Medical OfficerApr 06Sale16.228,000129,7840Apr 09 05:57 PM
FISHMAN ROBERT SChief Medical OfficerMar 07Option Exercise3.518,00028,0808,000Mar 08 07:11 PM
GALA RENEE DDirectorMar 07Buy15.539,000139,80210,000Mar 07 08:38 PM
FISHMAN ROBERT SChief Medical OfficerMar 07Sale15.678,000125,3230Mar 08 07:11 PM
GALA RENEE DDirectorMar 06Buy15.301,00015,3001,000Mar 07 08:38 PM
FISHMAN ROBERT SChief Medical OfficerFeb 07Option Exercise3.518,00028,0808,000Feb 09 08:12 PM
FISHMAN ROBERT SChief Medical OfficerFeb 07Sale16.608,000132,7740Feb 09 08:12 PM
FISHMAN ROBERT SChief Medical OfficerJan 08Option Exercise3.518,00028,0808,000Jan 10 05:05 PM
FISHMAN ROBERT SChief Medical OfficerJan 08Sale18.678,000149,3490Jan 10 05:05 PM